Top Markets
#1 Smilek to the Bank Smilek to the Bank +50.56%
#2 Purr Purr +48.10%
#3 Pons Pons +21.27%
#4 Non-Playable Coin Non-Playable Coin +21.00%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +20.47%
#6 ApeX ApeX +20.21%
#7 OriginTrail OriginTrail +20.09%
#8 龙虾 (Lobster) 龙虾 (Lobster) +19.97%
#9 Zora Zora +16.31%
#10 Morpho Morpho +16.16%
Coin of the day
Smilek to the Bank Smilek to the Bank
Settings
Language
ENGLISH
Currency
USD
Theme
BioGend Therapeutics Co., Ltd. BioGend Therapeutics Co., Ltd.

BioGend Therapeutics Co., Ltd.

6733
Rank in Stocks #21371
This company specializes in the development of innovative regenerative... This company specializes in the development of innovative regenerative bio-orthopedic products. Its current pipeline includes BiG-001 and BiG-006, both of which are osteoinductive bone graft substitutes. Additionally, it is advancing BiG-009, an autologous cartilage repair system. Established in 2016, the firm's operations are based in Taipei, Taiwan.
Share Price
$0.81882497
Last synced: 2026-08-21
Market Cap
$108.85M
Change (1 day)
0.39%
Change (1 year)
-38.35%
Country
TW
Trade BioGend Therapeutics Co., Ltd. (6733)

Category

Healthcare
Earnings for BioGend Therapeutics Co., Ltd. (6733)
Earnings in 2026 TTM: 0
According to BioGend Therapeutics Co., Ltd. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for BioGend Therapeutics Co., Ltd. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH